Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Sep 19;4(9):101011.
doi: 10.1016/j.xcrm.2023.101011.

Where the metabolome meets the microbiome for pancreatic cancer detection

Lucy Oldfield  1 , Eithne Costello  2
Affiliations
Comment

Where the metabolome meets the microbiome for pancreatic cancer detection

Lucy Oldfield et al. Cell Rep Med. .

Abstract

Risk prediction tools for pancreatic cancer are urgently sought to facilitate screening. Irajizad et al.1 describe the performance of a risk predication model based on circulating microbial- and non-microbial metabolites for assessment of 5-year pancreatic cancer risk.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Comment on

  • A blood-based metabolomic signature predictive of risk for pancreatic cancer.
    Irajizad E, Kenney A, Tang T, Vykoukal J, Wu R, Murage E, Dennison JB, Sans M, Long JP, Loftus M, Chabot JA, Kluger MD, Kastrinos F, Brais L, Babic A, Jajoo K, Lee LS, Clancy TE, Ng K, Bullock A, Genkinger JM, Maitra A, Do KA, Yu B, Wolpin BM, Hanash S, Fahrmann JF. Irajizad E, et al. Cell Rep Med. 2023 Sep 19;4(9):101194. doi: 10.1016/j.xcrm.2023.101194. Cell Rep Med. 2023. PMID: 37729870 Free PMC article.

References

    1. Irajizad E., Kenney A., Tang T., Vykoukal J., Wu R., Murage E., et al. A blood-based metabolite panel predictive of risk for pancreatic cancer. Cell Rep Med. 2023;4:101194. - PMC - PubMed
    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA. Cancer J. Clin. 2021;71:209–249. - PubMed
    1. Pereira S.P., Oldfield L., Ney A., Hart P.A., Keane M.G., Pandol S.J., Li D., Greenhalf W., Jeon C.Y., Koay E.J., et al. Early detection of pancreatic cancer. Lancet. Gastroenterol. Hepatol. 2020;5:698–710. - PMC - PubMed
    1. Johnston C.D., Bullman S. The tumour-associated microbiome. Nat. Rev. Gastroenterol. Hepatol. 2022;19:347–348. - PMC - PubMed
    1. Miyabayashi K., Ijichi H., Fujishiro M. The Role of the Microbiome in Pancreatic Cancer. Cancers. 2022;14 - PMC - PubMed